HPQ Silicon Inc. announces independent verification that its pilot-scale fumed silica reactor produces material meeting commercial grade 150 specifications, replicating earlier lab results.
Ardena has finalized the sale of its Södertälje drug substance manufacturing facility in Sweden to Nanologica AB, with the site reverting to its original name Syntagon AB.
A new partnership between The Ottawa Hospital and University of Ottawa will relocate and expand biotherapeutics manufacturing, positioning Ottawa as a Canadian leader in medical research and biodefence capabilities.
Abstrax publishes a free 30-page guide offering cannabis-derived solution to prevent and reverse vape oil oxidation, addressing industry-wide discoloration issues.
Chloé Savard, a Montreal microbiologist, has built a following of one million on Instagram by sharing stunning microscopic art from her home lab, transforming a pandemic hobby into a thriving career.
Medicenna Therapeutics provides a 2026 outlook, highlighting strong clinical data for MDNA11 in advanced cancer and plans for a new bifunctional therapy, MDNA113. Read the latest on these Canadian biotech advancements.
Nvidia commits $1 billion to a joint AI laboratory with pharmaceutical giant Eli Lilly, aiming to automate and accelerate drug discovery. The Silicon Valley facility will bridge AI and lab science.
HydroGraph Clean Power deepens its partnership with the University of Manchester's Graphene Engineering Innovation Centre, gaining a dedicated lab and accelerating commercial projects. Discover the impact on North American innovation.
HPQ Silicon Inc. reports a year of strategic realignment, technical validation for its fumed silica reactor, and a clear path to revenue. Read about their 2025 progress.
Vancouver's Cannabix Technologies receives its first international distributor order for its BreathLogix alcohol screening devices from Australia, marking a key expansion for its workplace safety technology.
Cannabix Technologies Inc. releases new product videos for its Marijuana Breath Test, highlighting a solution for roadside and workplace safety as cannabis reclassification progresses in the U.S.
Winnipeg's Kane Biotech Inc. presented new clinical data on its revyve wound gel platform at the Innovations in Wound Healing meeting in Florida, highlighting improved healing for chronic and complex wounds.
UBC scientists develop a cleaner method to make rayon using microfibrillated cellulose, reducing harsh solvent use by up to 70%. A win for sustainable fashion and B.C.'s green economy.
Montreal's HPQ Silicon Inc. has closed a non-brokered private placement exceeding $1 million. The funds will accelerate the commercialization of its Fumed Silica, battery material, and green hydrogen technologies. Read the details.
China's biopharma industry is accelerating, fueled by record investment and streamlined supply chains. With faster development times and massive deals like AstraZeneca's $5.2B pact, the global drug innovation race is heating up. Discover the shift from ou
South Korean semiconductor giant SK hynix has developed edible computer chips, marking a revolutionary advancement in technology. Discover how this innovation could transform multiple industries.
Groundbreaking genome research uncovers pivotal moment in feline domestication history. Discover how cats became human companions and what this reveals about our shared past.
A Canadian company's groundbreaking multiple sclerosis research faced potential sabotage due to alleged market manipulation. Learn how this medical breakthrough survived the threat.
Groundbreaking research reveals nearly all dog breeds retain wolf DNA, challenging our understanding of canine evolution. Discover what this means for your pet.
23andMe Research Institute unveils major expansion of African genetic groups, helping people of African descent reconnect with their ancestral roots through detailed DNA analysis.
Groundbreaking research suggests mushrooms could transform neural technology. Discover how fungal networks might revolutionize organic computing and what this means for Canada's tech future.
Barbados partners with EarlyHealth Group to build a US$200 million life sciences hub, positioning the island as the Caribbean's premier pharmaceutical and research centre.
Eupraxia Pharmaceuticals reveals consistent 52-week data from RESOLVE trial, showing EP-104GI maintains clinical remission in eosinophilic esophagitis patients with strong safety profile.
C3i Center strengthens its leadership with Bobby Boursiquot as new VP of Commercialization to accelerate cell and gene therapy market transfer. Discover how this impacts Canadian biotech.
Nobel laureate James Watson, who co-discovered DNA's double helix, has died at 97. Explore his groundbreaking legacy and controversial later years.
Nobel laureate James Watson, who co-discovered DNA's double-helix structure, has passed away at 97. Explore his groundbreaking legacy and scientific impact.
Optigo Biotherapeutics strengthens leadership with renowned pharmaceutical expert Dr. Andreas Wallnofer joining its Board of Directors as the company progresses toward Investigational New Drug (IND) enabling studies.
Winnipeg-based Kane Biotech Inc. reveals groundbreaking clinical data demonstrating Revyve™'s effectiveness in treating chronic wounds, presenting new hope for diabetic foot ulcers and severe burn patients.
Calgary-based Litus LINC achieves commercial viability with groundbreaking nanotechnology that extracts lithium from challenging sources with unprecedented efficiency and environmental benefits.
Ardena strengthens its leadership with strategic hires of Chief Quality Officer and Chief Information Officer to drive operational excellence and digital transformation in pharmaceutical services.